Company intelligence / Profile preview

SoranusMED

Ownership: Private
Development stage: Other

Overview

SoranusMED is developing innovative, non-invasive and minimally invasive medical devices for the treatment of pelvic floor disorders. Their portfolio includes surgical devices for stress urinary incontinence, pelvic organ prolapse, and a neuromodulator for overactive bladder. The company has received funding from the European Union’s Horizon 2020 research program.

Therapeutic areas: UrologyWomen's Health
Modalities: DeviceNeuromodulatorSurgical device
Industry: Therapeutic Medical Devices

Partnerships

European Union Horizon 2020 research program [project funding]

Beyond the preview

Go deeper on SoranusMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SoranusMED.

Explore the full profile